Table 1.
Infectious disease | Organism | Vector | Complications in pregnancy | Vertical transmission | Prophylaxis/vaccination | Treatment in pregnancy | |
---|---|---|---|---|---|---|---|
Mosquito borne | |||||||
Malaria | protozoa |
P. falciparum
P. vivax P. ovale |
Ae. aegypti | Low endemicity: risk of severe infection with maternal/foetal loss29
High endemicity: occult infections30 |
Accumulation in placenta but no vertical transmission | Doxycycline contraindicated ITNs RTS,S vaccine in development25 |
1T: Primaquine + clindamycin33
2–3T: ACT IPTp (sulfadoxine-pyrimethamine)33 |
Dengue | flavivirus | Dengue virus |
Ae. aegypti
Ae. albopictus |
Increased risk of DHF and DHS54
Increased pre-eclampsia, obstetric haemorrhage, miscarriage, pre-term delivery55–57 |
1.6% transmission in cohort of 6564
One prospective study reports 18.5–22.7%65 |
CYD-DTV vaccine53 | Supportive, monitor for need of C-section |
Zika | flavivirus | Zika virus | Ae. aegypti | IUGR, oligohydramnios, stillbirth, miscarriage72 | CZS (microcephaly, ventriculomegaly)11 | 2 vaccines in phase II trials (VRC 705, mRNA 1325)75 | Supportive |
Japanese encephalitis | flavivirus | Japanese encephalitis | Culux | Miscarriage, stillbirth. Outcomes similar in 3T infections compared with background population.79 | Virus identified in brain and liver of stillborn79 | Vaccine available IXIARO®, live attenuated vaccine80,81 not approved in pregnancy | Supportive |
Chikungunya | togavirus | Chikungunya virus | Ae. Albopictus | Increased rate of admission84
Sepsis syndrome in mother17 |
Occurs in antepartum period, 50% of newborns develop severe complications12,17 | Standard protective measures | Supportive |
Tick borne | |||||||
Lyme disease | spirochete bacterium |
B. burgdorferi
s.l. complex (incl afzelii, garinii, miyamoti) |
I. scapilaris
I. ricinus I. pacificus I. persulcatus |
Stillbirth102
Possible congenital malformation including cardiac98 |
Spirochetemia of newborn,91–93 ECM rash96 | Standard protective measures | Doxycycline contraindicated Amoxicillin 500 mg TID x14–21 days105 Ceftriaxone 2 g OD104–106 |
Human Granulocytic Anaplasmosis | gram negative bacterium | Anaplasma phagocytophilum |
I. scapilaris
I. pacificus |
Mild symptomatic course in pregnancy.115 Miscarriage has been described113 | Case reports of vertical transmission. No vertical transmission seen in treated mothers114,115 | Standard protective measures | Doxycycline contraindicated (but has been used in some cases) Rifampicin 10 mg/kg bd × 5–7 days110,111 Penicillin if LD coinfection suspected |
Human Monocytic Ehrlichiosis | gram negative bacterium | Ehrlichia chaffensis | Lone star tick Amblyomma (dog tick) |
Minimal data. One case of a mother who developed appendicitis and had good outcome for mother and baby116 | No data | Standard protective measures | Doxycycline used in one case with good outcome7
Rifampicin 10 mg/kg bd × 5–7 days110,111 |
Babesiosis | protozoa |
Babesia microti
Babesia divergens |
I. scapilaris
I. pacificus I. ricinus |
Severe infection mimicking HELLP syndrome seen in pregnancy14 | Rare, congenital syndrome of fever, thrombocytopenia, anaemia124 | Standard protective measures | Clindamycin 600 mg PO TID + quinine 650 mg PO TID × 7–10 days (better placental penetration than standard atovaquone and azithromycin)14 |
Tick-borne encephalitis | flavivirus | Tick-borne encephalitis |
I persulcatus
I ricinus |
Limited data, self-limiting illness, no evidence of adverse events in pregnancy | No evidence of vertical transmission in a single case of infection in pregnancy130 | Standard protective measures | Inactivated vaccine available risk/benefit analysis for use in pregnancy131 |
Relapsing Fever | spirochete bacteria |
B. miyamoti (seven other species)
B. recurrentis |
Ornithodoros (soft shell ticks) Ixodids lice |
Decreased birth weight, pre-term delivery, miscarriage134,135 | Transmission in utero and during pregnancy136,138 | Standard protective measures | Doxycycline contraindicated Erythromycin139
- 7–10 days TBRF - single dose LBRF |
Rickettsial diseases | |||||||
Rocky Mountain Spotted Fever | proteobacterium | Rickettsia rickettseii | (Hardshell tick) Dermacentor variabilis Dermacentor andersoni |
Adverse outcomes in pregnancy. Case series of 10 pregnancies, 3 maternal deaths, 3 miscarriages, 3 neonatal deaths144 | No evidence of vertical transmission | Standard protective measures | Chloramphenicol 50–75 mg/kg in 4 divided doses for 5–7 days or until afebrile for 48–72 h. Doxycycline IV in severe cases143 |
ET | proteobacterium | Rickettsia prowazekii | (Human louse) Pediculosis humanus |
No evidence for increased complication rate in pregnancy | No evidence of vertical transmission | Sanitation/hygiene | |
ST | proteobacterium | Orientalis tsutsugamushi | (Mite) Leptotrombidium | High levels of adverse outcomes in all trimesters including miscarriage, maternal death in some cases in studies of both ST and MT151,152 | No evidence of vertical transmission | Standard protective measures | Doxycycline, azithromycin, rifampicin155 |
MT | proteobacterium | Rickettsia typhi | (Rat flea) Xenopsylla cheopis |
No evidence of vertical transmission | Standard protective measures | Doxycycline153
(azithromycin inferior) |
|
Fly borne diseases | |||||||
Chagas disease | protozoa | Trypanosoma cruzii | (reduviid bug) Triatima infestans Rhodnius prolixans |
Maternal infection does not appear to have negative outcomes during pregnancy or delivery161 | Congenital CD in 5% of cases. Associated with prematurity, low birth weight, hepatosplenomegaly, anaemia, thrombocytopenia161 | Standard protective measures | Treatment of mothers not advised during pregnancy163
Benznidazole and nifurtimox in newborn children min. 60 days of therapy164 |
Leishmaniasis | protozoa |
Leishmania: infantum donovani aethiopica |
(sandfly) New world: Lutzomyia Old world: Phlebotomus |
Hepatosplenomegaly in pregnancy can be occult due to the increasing size of the uterus | A systematic review of 17 vertical transmissions showed 27% neonatal mortality169 | Standard protective measures | Liposomal Amphotericin B safe but difficult to procure in resource limited settings. Miltefosine and pentavalent antimony are not advised in pregnancy due to teratogenicity and lack of data respectively |
Bartonellosis (Carrion’s disease) |
proteobacterium |
Bartonella
bacilliformis |
(sandfly) Lutzomyia verrucarum |
Carrion’s disease is associated with high maternal mortality, miscarriage, preterm birth and foetal death174 | Vertical transmission is described in case reports175 | Standard protective measures | Chloramphenicol is the mainstay of treatment, ciprofloxacin, rifampicin and streptomycin have also been used. No data exists on treatment of pregnant173 |
ET, epidemic typhus; HELLP, haemolytic anaemia, low platelets, elevated liver enzymes; IUGR, intrauterine growth restriction; LBRF, louse-borne relapsing fever; LD, Lyme disease; MT, murine typhus, ST, scrub typhus; TBRF, tick-borne relapsing fever.